{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:51:48Z","timestamp":1792792308404,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,27]],"date-time":"2014-02-27T00:00:00Z","timestamp":1393459200000},"content-version":"vor","delay-in-days":332,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.vaccine.2012.11.106","type":"journal-article","created":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T12:41:57Z","timestamp":1366202517000},"page":"B209-B215","source":"Crossref","is-referenced-by-count":224,"special_numbering":"S2","title":["Strategic priorities for respiratory syncytial virus (RSV) vaccine development"],"prefix":"10.1016","volume":"31","author":[{"given":"L.J.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.R.","family":"Dormitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"Nokes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Rappuoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Roca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.S.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.11.106_bib0005","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMoa0804877","article-title":"The burden of respiratory syncytial virus infection in young children","volume":"360","author":"Hall","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0010","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis","volume":"375","author":"Nair","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0015","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/jama.282.15.1440","article-title":"Bronchiolitis-associated hospitalizations among U.S. children, 1980\u20131995","volume":"282","author":"Shay","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-065X.2010.00972.x","article-title":"Biological challenges and technological opportunities for respiratory syncytial virus vaccine development","volume":"239","author":"Graham","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0025","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1586\/erv.11.120","article-title":"Respiratory syncytial virus vaccine development","volume":"10","author":"Hurwitz","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0030","doi-asserted-by":"crossref","first-page":"7285","DOI":"10.1016\/j.vaccine.2011.07.114","article-title":"RSV 2010: recent advances in research on respiratory syncytial virus and other pneumoviruses","volume":"29","author":"van Bleek","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0035","doi-asserted-by":"crossref","first-page":"232","DOI":"10.5483\/BMBRep.2011.44.4.232","article-title":"Current progress on development of respiratory syncytial virus vaccine","volume":"44","author":"Chang","year":"2011","journal-title":"BMB Reports"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0040","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virusres.2011.09.020","article-title":"Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years","volume":"162","author":"Collins","year":"2011","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0045","first-page":"543","article-title":"Risk of primary infection and reinfection with respiratory syncytial virus","volume":"140","author":"Glezen","year":"1986","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1086\/524019","article-title":"Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya","volume":"46","author":"Nokes","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0055","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/(SICI)1096-9071(199807)55:3<234::AID-JMV9>3.0.CO;2-2","article-title":"Seroepidemiological study of respiratory syncytial virus in Sao Paulo state, Brazil","volume":"55","author":"Cox","year":"1998","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0060","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1056\/NEJM197903083001004","article-title":"Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children","volume":"300","author":"Henderson","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0065","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa043951","article-title":"Respiratory syncytial virus infection in elderly and high-risk adults","volume":"352","author":"Falsey","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0070","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2174\/1874285801105010144","article-title":"Risk factors for severe respiratory syncytial virus lower respiratory tract infection","volume":"5","author":"Sommer","year":"2011","journal-title":"Open Microbiol J"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0075","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/INF.0b013e31822e68e6","article-title":"Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997\u20132006","volume":"31","author":"Stockman","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0080","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S1526-0542(03)00033-2","article-title":"Immunology of viral respiratory tract infection in infancy","volume":"4","author":"Crowe","year":"2003","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/INF.0b013e3181f232fe","article-title":"Etiology and epidemiology of viral pneumonia among hospitalized children in rural Mozambique: a malaria endemic area with high prevalence of human immunodeficiency virus","volume":"30","author":"O\u2019Callaghan-Gordo","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0090","first-page":"914","article-title":"Respiratory syncytial virus infection: denominator-based studies in Indonesia, Mozambique, Nigeria and South Africa","volume":"82","author":"Robertson","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0095","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1067\/mpd.2000.105350","article-title":"Increased burden of respiratory viral associated severe lower respiratory tract infections in children infected with human immunodeficiency virus type-1","volume":"137","author":"Madhi","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0100","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/oxfordjournals.aje.a120957","article-title":"Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population","volume":"89","author":"Chin","year":"1969","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0105","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/oxfordjournals.aje.a120956","article-title":"Respiratory virus immunization: I. A field of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine","volume":"89","author":"Fulginiti","year":"1969","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0110","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/oxfordjournals.aje.a120954","article-title":"An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine","volume":"89","author":"Kapikian","year":"1969","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0115","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0120","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1586\/eri.11.92","article-title":"Evidence for a causal relationship between respiratory syncytial virus infection and asthma","volume":"9","author":"Wu","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0125","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJM199311183292102","article-title":"Prophylactic administration of respiratory syncytial virus immune globulin in high-risk infants and young children","volume":"329","author":"Groothuis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0130","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0022-3476(81)80829-3","article-title":"Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level","volume":"98","author":"Glezen","year":"1981","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0135","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/infdis\/134.3.211","article-title":"Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus","volume":"134","author":"Lamprecht","year":"1981","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0140","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jaci.2008.10.043","article-title":"Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze","volume":"123","author":"Stensballe","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0145","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1017\/S0950268809991373","article-title":"Mathematical modelling of respiratory syncytial virus (RSV): vaccination strategies and budget applications","volume":"138","author":"Acedo","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0150","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1086\/425981","article-title":"Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children","volume":"190","author":"Belshe","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0155","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1086\/427813","article-title":"Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants","volume":"191","author":"Karron","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0160","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1016\/j.vaccine.2009.07.022","article-title":"Codon stabilization analysis of the 248 temperature sensitive mutation for increased phenotypic stability of respiratory syncytial virus vaccine candidates","volume":"27","author":"Luongo","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0165","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/infdis\/145.3.311","article-title":"Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial","volume":"145","author":"Belshe","year":"1982","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0170","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1542\/peds.102.3.531","article-title":"Palivizumab, a humanized respiratory syncytial virus monclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants","volume":"102","author":"The IMpact-RSV Study Group","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0175","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1203\/PDR.0b013e318220a553","article-title":"A randomized controlled trial of motavizumab versus palivizumab for the prophylaxis of serious respiratory syncytial virus disease in children with hemodynamically significant congenital heart disease","volume":"70","author":"Feltes","year":"2011","journal-title":"Pediatr Res"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0180","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/INF.0b013e31823386f1","article-title":"Phase 1 study of the safety and immunogenicity of a live, attenuated respiratory syncytial virus and parainfluenza virus type 3 vaccine in seronegative children","volume":"31","author":"Bernstein","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0185","doi-asserted-by":"crossref","first-page":"6935","DOI":"10.1128\/JVI.71.9.6935-6939.1997","article-title":"Priming with live respiratory syncytial virus (RSV) prevents enhanced pulmonary inflammatory responses associated with formalin inactivated RSV immunization in BALB\/c mice","volume":"71","author":"Waris","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0190","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1086\/592168","article-title":"Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (RSV) vaccines\u2014nonadjuvanted vaccine or vaccine adjuvanted with alum\u2014given concomitantly with influenza vaccine to high-risk elderly individuals","volume":"198","author":"Falsey","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0195","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1086\/517377","article-title":"Safety and immunogenicity of a purified F protein respiratory syncytial virus (PFP-2) vaccine in seropositive children with bronchopulmonary dysplasia","volume":"177","author":"Groothuis","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0200","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2217\/fmb.10.22","article-title":"Prospects for defined epitope vaccines for respiratory syncytial virus","volume":"5","author":"Anderson","year":"2010","journal-title":"Future Microbiol"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0205","doi-asserted-by":"crossref","first-page":"9632","DOI":"10.1128\/JVI.00451-10","article-title":"Prophylactic treatment with a G glycoprotein monoclonal antibody reduces pulmonary inflammation in respiratory syncytial virus (RSV)-challenged naive and formalin-inactivated RSV-immunized BALB\/c mice","volume":"84","author":"Radu","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2012.11.106_bib0210","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/ije\/28.1.157","article-title":"Risk factors for severe respiratory syncytial virus infection leading to hospital admission in children in the Western Region of The Gambia","volume":"28","author":"Weber","year":"1999","journal-title":"Int J Epidemiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13000509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13000509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T14:31:52Z","timestamp":1595687512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13000509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":42,"alternative-id":["S0264410X13000509"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.11.106","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}